Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton’s tyrosine kinase inhibitor

• Alison H. Kucharik, MD,
• Nina B. Curkovic, BS,
• Julio C. Chavez, MD,
• Kenneth Y. Tsai, MD, PhD,
• Andrew S. Brohl, MD,
• James M. Grichnik, MD, PhD

Affiliations

Alison H. Kucharik, MD

Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida

Nina B. Curkovic, BS

Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

Julio C. Chavez, MD

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Kenneth Y. Tsai, MD, PhD

Department of Pathology, Division of Dermatopathology, Moffitt Cancer Center, Tampa, Florida

Andrew S. Brohl, MD

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida

James M. Grichnik, MD, PhD

Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida; Correspondence to: James M. Grichnik, MD, PhD, Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, 13330 USF Laurel Drive, Tampa, FL 33620.